Sfoglia per AUTORE
PARVIS G
Collezione AOU San Luigi di Orbassano

  

Items : 12

2020
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Rambaldi A; Gallamini A; Massimo Gianni A; Biggi A; Chauvie S; Viero P; Ferreri AJM; Gini G; Schiavotto C; Zanotti R; Parvis G; Corradini P; Cimminiello M; Gavarotti P; Bolis S; Zoli V; Trentin L; La Nasa G; Cantonetti M; Picardi M; Rossi A; Patti C; Viviani S; Di Raimondo F; Tarella C; Pavoni C; Romano A;

2019
AOU Alessandria
AOU San Luigi di Orbassano

Mantoan B; Gueli A; Billio A; Angrilli F; Perrone T; Lanza F; Semenzato G; Parvis G; Dondi A; Narni F; Zallio F; Zoli V; Devizzi L; Tucci A; Di Raimondo F; Stelitano C; Rota-Scalabrini D; Ciceri F; Rossini F; Castellino C; Gini G; Liberati AM; Musso M; Pulsoni A; Barbui AM; Patti C; Boccomini C; Benedetti F; Bruna R; et alii...

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2018 Feb 10;36(5):454-462. doi: 10.1200/JCO.2017.75.2543. Epub 2018 Jan 23.
2018
AO Cuneo
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Rambaldi A; Gianni AM; Pavoni C; Chauvie S; Bergesio F; Prosperini G; Chiaravalloti A; Gregianin M; Ficola U; Fallanca F; Biggi A; Avigdor A; Billio A; Miglino M; Viero P; Ferreri AJM; Gini G; Zanotti R; Parvis G; Schiavotto C; Cimminiello M; Corradini P; Gavarotti P; Battistini R; Gottardi D; Rapezzi D; Bolis S; Trentin L; La Nasa G; et alii...

Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated/deleted clones. in Oncotarget / Oncotarget. 2017 May 30;8(22):35508-35522. doi: 10.18632/oncotarget.16348.
2017
AOU San Luigi di Orbassano

Carrà G; Panuzzo C; Torti D; Parvis G; Crivellaro S; Familiari U; Volante M; Morena D; Lingua MF; Brancaccio M; Guerrasio A; Pandolfi PP; Saglio G; Taulli R; Morotti A;

Potential Benefit of Involved-Field Radiotherapy for Patients With Relapsed-Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2017 Jan;17(1):14-22. doi: 10.1016/j.clml.2016.09.008. Epub 2016 Sep 17.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ricardi U; Vitolo U; Parvis G; Gottardi D; Freilone R; Nicolosi M; Botto B; Pregno P; Gavarotti P; Filippi AR; Levis M; Piva C;

2016
AOU San Luigi di Orbassano

Priola AM; Priola SM; Gned D; Piacibello E; Sardo D; Parvis G; Torti D; Ardissone F; Veltri A;

Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study. in International journal of radiation oncology, biology, physics / Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):783-91. doi: 10.1016/j.ijrobp.2015.12.019. Epub 2015
2016
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Ricardi U; Tarella C; Ladetto M; Olivieri A; Gini G; Parvis G; Corradini P; Di Nicola M; Matteucci P; Caracciolo D; Passera R; Di Russo A; Magni M; Filippi AR; Bruna R; Devizzi L; Ruella M;

Usefulness of diffusion-weighted magnetic resonance imaging for assessing early treatment response in lymphoma patients. in Acta radiologica (Stockholm, Sweden : 1987) / Acta Radiol. 2015 Feb;56(2):NP10-1. doi: 10.1177/0284185114554254. Epub 2014 Oct 20.
2015
AOU San Luigi di Orbassano

Priola AM; Gned D; Parvis G; Torti D; Priola SM;

Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italiana Linfomi. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2013 Sep 20;31(27):3351-9. doi: 10.1200/JCO.2012.44.8290. Epub 2013 Aug 19.
2013
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ladetto M; Boccomini C; Baldini L; De Angelis F; Tucci A; Botto B; Chiappella A; Vitolo U; Chiarenza A; Pinto A; De Renzo A; Zaja F; Castellino C; Bari A; Alvarez De Celis I; Evangelista A; Parvis G; Gamba E; Lobetti-Bodoni C; Ciccone G; Rossi G;

Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2011 Mar 1;29(7):814-24. doi: 10.1200/JCO.2010.28.9777. Epub 2010 Dec 28.
2011
AOU San Luigi di Orbassano

Tarella C; Passera R; Magni M; Benedetti F; Rossi A; Gueli A; Patti C; Parvis G; Ciceri F; Gallamini A; Cortelazzo S; Zoli V; Corradini P; Carobbio A; Mulé A; Bosa M; Barbui A; Di Nicola M; Sorio M; Caracciolo D; Gianni AM; Rambaldi A;

Follow-up of mediastinal lymphoma: role of ultrasonography. in La Radiologia medica / Radiol Med. 2006 Sep;111(6):759-72. doi: 10.1007/s11547-006-0070-z. Epub 2006 Aug 11.
2006
AOU San Luigi di Orbassano

De Pascale A; Giorcelli R; Garofalo G; Perotto F; Parvis G; Gino M; Fava C;

CT findings in primary pulmonary lymphomas. in La Radiologia medica / Radiol Med. 2005 Nov-Dec;110(5-6):554-60.
2005
AOU San Luigi di Orbassano

Cardinale L; Allasia M; Cataldi A; Ferraris F; Parvis G; Fava C;